This is a preview of subscription content, log in via an institution to check access.
Notes
The study was supported by research funding from Boehringer Ingelheim Pharmaceuticals, Inc.
Reference
Meyers J, et al. Medicare Fee-for-Service Enrollees with Primary Acute Myeloid Leukemia: An Analysis of Treatment Patterns, Survival, and Healthcare Resource Utilization and Costs. Applied Health Economics and Health Policy : 16 May 2013. Available from: URL: http://dx.doi.org/10.1007/s40258-013-0032-2
Rights and permissions
About this article
Cite this article
AML in the elderly: poor treatment outcomes, high cost. PharmacoEcon Outcomes News 679, 4 (2013). https://doi.org/10.1007/s40274-013-0428-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0428-0